financetom
Business
financetom
/
Business
/
Target Faces Uncertain Shorter-Term Setup, Oppenheimer Says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Target Faces Uncertain Shorter-Term Setup, Oppenheimer Says
Feb 26, 2025 10:20 AM

12:51 PM EST, 02/26/2025 (MT Newswires) -- Target's ( TGT ) Q4 results should at least meet the midpoint of earnings guidance, Oppenheimer said in a report Wednesday.

"TGT is positioned to deliver Q4 EPS at least in line with the midpoint of management guidance of $1.85-2.45," Oppenheimer analysts Rupesh Parikh and Erica Eiler said.

They said this is predicated on a comp increase of about 1.5%, consistent with management's mid-January update.

Amidst accelerating inflation lately, tariff uncertainty, and higher interest rates, the analysts said the discretionary goods rebound is unlikely to be a straight line from here.

"TGT could continue to see some growth challenges in its discretionary categories such as home and hardlines, suggesting to us the potential for a below algorithm top-line guide," they said. Its Q4 results are due March 4.

Oppenheimer kept its outperform rating with a price target of $165.

Price: 124.13, Change: -3.26, Percent Change: -2.56

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Biogen, Dayra Therapeutics Collaborate to Develop Oral Macrocyclic Peptides
Biogen, Dayra Therapeutics Collaborate to Develop Oral Macrocyclic Peptides
Nov 24, 2025
08:29 AM EST, 11/24/2025 (MT Newswires) -- Biogen (BIIB) and Dayra Therapeutics said Monday they have entered a collaboration to research and develop oral macrocyclic peptides for priority targets in immunological conditions. The companies said the macrocyclic peptides have potential to deliver biologic-like efficacy and safety in an oral format and target protein binding sites that are challenging for small...
Grindr Special Committee Ceases Engagement with Respect to Unsolicited Take-Private Proposal from Large Shareholders
Grindr Special Committee Ceases Engagement with Respect to Unsolicited Take-Private Proposal from Large Shareholders
Nov 24, 2025
WEST HOLLYWOOD, Calif.--(BUSINESS WIRE)-- Grindr Inc. ( GRND ) (“Grindr” or the “Company”), the Global Gayborhood in Your Pocket™, today announced that the Special Committee (the “Special Committee”) of its Board of Directors (the “Board”) has determined to cease engagement with respect to a non-binding, unsolicited take-private proposal (the “Proposal”) from large shareholders Ray Zage and James Lu (the “Proposing...
AVAX One's Treasury Holdings Reach Over 13.8 Million AVAX as of November 23, 2025
AVAX One's Treasury Holdings Reach Over 13.8 Million AVAX as of November 23, 2025
Nov 24, 2025
Approximately $35 Million+ in Cash Still Available for Stock Repurchases and Additional AVAX Token Acquisitions VANCOUVER, BC and WEST PALM BEACH, Fla., Nov. 24, 2025 /PRNewswire/ -- AVAX One Technology Ltd. (AVAX One ( AVX ) or the Company), today announced the acquisition of 9,377,475 additional AVAX between November 5 and 23, 2025 for an aggregate consideration of $110 million, reflecting...
Bank of Nova Scotia Gets Regulatory Approvals to Transfer Latin American Banking Operations to Davivienda
Bank of Nova Scotia Gets Regulatory Approvals to Transfer Latin American Banking Operations to Davivienda
Nov 24, 2025
08:28 AM EST, 11/24/2025 (MT Newswires) -- Bank of Nova Scotia ( BNS ) and Davivienda said Monday that they have received all regulatory approvals to complete the transfer of the Canadian lender's banking operations in Colombia, Costa Rica, and Panama to Davivienda. The combined operations of both parties will now operate under a new holding company, Davivienda Group, the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved